Results 131 to 140 of about 11,617 (148)

A preclinical and clinical review of aflibercept for the management of cancer

Cancer Treatment Reviews, 2012
Andrew Gaya
exaly  

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Annals of Oncology, 2016
Stephen P Ackland, Ralf Hofheinz, Timothy Iveson   +2 more
exaly  

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Gynecologic Oncology, 2012
Robert L Coleman, R Katherine Alpaugh, D Scott Mcmeekin   +2 more
exaly  

A novel LC-MS/MS approach to the pharmacokinetic study of free and bound aflibercept simultaneously

Analytical and Bioanalytical Chemistry, 2020
Fei Yu, Fangjie Liu, Liu Wanhui
exaly  

Aflibercept: A Review in Metastatic Colorectal Cancer

Drugs, 2015
Yahiya Y Syed, Syed Yahiya Y, Mckeage Kate   +2 more
exaly  

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

European Journal of Cancer, 2014
Josep Tabernero, Paul Ruff, Vladimir Moiseyenko   +2 more
exaly  

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

European Journal of Cancer, 2013
Philip Philip, Armando Santoro, Yves Humblet   +2 more
exaly  

Aflibercept

Reactions Weekly, 2015
  +4 more sources

Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway

Biochemical Pharmacology, 2019
Salvatore Salomone, Giovanni Giurdanella, Claudio Bucolo   +2 more
exaly  

The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOS/NO signaling in mice

Acta Pharmacologica Sinica, 2020
Hui-Hua Li, Bo Zhang, Ming-Ming Wu
exaly